United States · FDA National Drug Code directory
NUFYMCO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70710-2173_4a45dd5a-c8d9-4e98-9586-ab6c069c2ffe
- Product NDC
- 70710-2173
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ranibizumab-leyk
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260611
- Source listing expiry
- 20271231
Source-listed ingredients
- RANIBIZUMAB — .5 mg/.05mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (70710-2173-1) / .05 mL in 1 VIAL, GLASS · 70710-2173-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →